Journal of Neuroinflammation

Table 2 CSF sTREM2 Spearman’s Rho correlations in the hip fracture cohort

From: CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau

	PATIENTS WITHOUT DEMENTIA						PATIENTS WITH DEMENTIA
	All		No delirium		Delirium		All		No delirium		Delirium
N	59		44		15		61 (60)		10		50
	Rho	p	Rho	p	Rho	p	Rho	p	Rho	p	Rho	p
Age	0.21	0.12	0.12	0.43	0.23	0.40	0.00	0.98	0.16	0.66	-0.05	0.74
Time to surgery (hours) *	0.01	0.93	-0.03	0.83	0.06	0.84	0.39	0.002	0.43	0.21	0.40	0.005
CSF Biomarkers
N	57		44		13		60		9		50
	Rho	p	Rho	p	Rho	p	Rho	p	Rho	p	Rho	p
CSF Aβ42 (pg/ml)	0.11	0.40	0.20	0.18	0.31	0.30	0.40	0.002	0.02	0.97	0.53	<0.001
CSF Aβ38 (pg/ml) MSD	0.09	0.49	0.06	0.71	0.18	0.55	0.44	<0.001	0.40	0.29	0.45	0.001
CSF Aβ40 (pg/ml) MSD	0.14	0.32	0.12	0.44	0.23	0.45	0.48	<0.001	0.37	0.33	0.51	<0.001
CSF Aβ42 (pg/ml) MSD	0.09	0.52	0.24	0.12	-0.13	0.67	0.43	0.001	0.15	0.70	0.53	<0.001
CSF t-tau (pg/ml)	0.14	0.28	-0.04	0.82	0.20	0.51	0.46	<0.001	0.83	0.005	0.34	0.016
CSF p-tau (pg/ml)	0.12	0.38	-0.02	0.90	0.23	0.46	0.49	<0.001	0.77	0.016	0.37	0.008

Aβ42, amyloid beta 1–42; t-tau, total-tau; p-tau, phosphorylated tau; sTREM2, soluble triggering receptor expressed on myeloid cells
*Time to surgery, hours from hospital admission to surgery (onset of anesthesia) and CSF sampling

Back to article page

ISSN: 1742-2094

Contact us

Submission enquiries: journalsubmissions@springernature.com